Dianthus Therapeutics, Inc. /DE/ Quarterly Return On Equity in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q2 2024.
  • Dianthus Therapeutics, Inc. /DE/ Return On Equity for the quarter ending June 30, 2024 was -21 %, a 128% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2023 was -74.2 %, a 184% decline from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2022 was 88.5 %.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2021 was -10.4 %, a 84.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -21 -96.5 -128% Apr 1, 2024 Jun 30, 2024
Q1 2024 -30.5 -108 -139% Jan 1, 2024 Mar 31, 2024
Q4 2023 -74.2 -163 -184% Oct 1, 2023 Dec 31, 2023
Q3 2023 -793 -713 -889% Jul 1, 2023 Sep 30, 2023
Q2 2023 75.5 +40.6 +116% Apr 1, 2023 Jun 30, 2023
Q1 2023 78 +78.5 Jan 1, 2023 Mar 31, 2023
Q4 2022 88.5 +98.9 Oct 1, 2022 Dec 31, 2022
Q3 2022 -80.3 -26.1 -48.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 34.9 +92.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -0.57 +62.8 +99.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -10.4 +55.7 +84.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -54.1 -0.7 -1.31% Jul 1, 2021 Sep 30, 2021
Q2 2021 -57.8 -2.44 -4.41% Apr 1, 2021 Jun 30, 2021
Q1 2021 -63.3 -9.4 -17.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -66.1 -16.2 -32.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -53.4 -8.18 -18.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -55.4 -13.2 -31.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -53.9 -13.9 -34.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.8 +4.2 +7.77% Oct 1, 2019 Dec 31, 2019
Q3 2019 -45.2 +36.9 +44.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.2 Apr 1, 2019 Jun 30, 2019
Q1 2019 -40 Jan 1, 2019 Mar 31, 2019
Q4 2018 -54 Oct 1, 2018 Dec 31, 2018
Q3 2018 -82.1 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.